Toppgene analysis for aggregated_1964_log, IC5, positive side

Go To Start Page
Input Parameters [Show Detail]
Training Results [Expand All] [Download All] [Sparse Matrix]
Display pValues and Scores as Table row limit

1: GO: Molecular Function [Display Chart] 809 annotations before applied cutoff / 18819 genes in category

ID Name Source pValue FDR B&H FDR B&Y Bonferroni Genes from Input Genes in Annotation
1 GO:0061659 ubiquitin-like protein ligase activity 8.188E-5 4.540E-2
3.302E-1
6.624E-2
 12 217
2 GO:0016763 transferase activity, transferring pentosyl groups 1.559E-4 4.540E-2
3.302E-1
1.261E-1
 6 56
3 GO:0051800 phosphatidylinositol-3,4-bisphosphate 3-phosphatase activity 2.097E-4 4.540E-2
3.302E-1
1.696E-1
 2 2
4 GO:0001046 core promoter sequence-specific DNA binding 2.744E-4 4.540E-2
3.302E-1
2.220E-1
 8 115
5 GO:0061630 ubiquitin protein ligase activity 2.806E-4 4.540E-2
3.302E-1
2.270E-1
 11 212

2: GO: Biological Process [Display Chart] 4075 annotations before applied cutoff / 18785 genes in category

ID Name Source pValue FDR B&H FDR B&Y Bonferroni Genes from Input Genes in Annotation
1 GO:1903320 regulation of protein modification by small protein conjugation or removal 1.277E-6 5.203E-3 4.626E-2 5.203E-3 17 290
2 GO:0018205 peptidyl-lysine modification 5.267E-6 7.218E-3
6.417E-2
 2.146E-2 20 430
3 GO:0016569 covalent chromatin modification 5.314E-6 7.218E-3
6.417E-2
 2.165E-2 21 468
4 GO:1902275 regulation of chromatin organization 7.906E-6 7.700E-3
6.845E-2
 3.222E-2 12 171
5 GO:0009896 positive regulation of catabolic process 1.099E-5 7.700E-3
6.845E-2
 4.477E-2 19 414
6 GO:0016570 histone modification 1.134E-5 7.700E-3
6.845E-2
 4.620E-2 20 453
7 GO:0035148 tube formation 2.291E-5 1.334E-2
1.186E-1
9.335E-2
 11 160
8 GO:0048511 rhythmic process 2.954E-5 1.505E-2
1.338E-1
1.204E-1
 17 368
9 GO:0016925 protein sumoylation 3.894E-5 1.763E-2
1.567E-1
1.587E-1
 10 140
10 GO:0001838 embryonic epithelial tube formation 4.952E-5 1.783E-2
1.585E-1
2.018E-1
 10 144
11 GO:0050872 white fat cell differentiation 5.250E-5 1.783E-2
1.585E-1
2.139E-1
 4 15
12 GO:0072175 epithelial tube formation 5.252E-5 1.783E-2
1.585E-1
2.140E-1
 10 145
13 GO:0050679 positive regulation of epithelial cell proliferation 5.796E-5 1.817E-2
1.615E-1
2.362E-1
 11 177
14 GO:0001841 neural tube formation 7.390E-5 2.151E-2
1.912E-1
3.011E-1
 9 122
15 GO:0035067 negative regulation of histone acetylation 8.946E-5 2.315E-2
2.058E-1
3.646E-1
 4 17
16 GO:0050678 regulation of epithelial cell proliferation 9.089E-5 2.315E-2
2.058E-1
3.704E-1
 15 326
17 GO:0060613 fat pad development 1.018E-4 2.439E-2
2.169E-1
4.147E-1
 3 7
18 GO:0010560 positive regulation of glycoprotein biosynthetic process 1.137E-4 2.574E-2
2.289E-1
4.634E-1
 4 18
19 GO:1903311 regulation of mRNA metabolic process 1.279E-4 2.743E-2
2.438E-1
5.212E-1
 9 131
20 GO:0031396 regulation of protein ubiquitination 1.531E-4 3.120E-2
2.773E-1
6.240E-1
 13 267
21 GO:0051446 positive regulation of meiotic cell cycle 1.760E-4 3.259E-2
2.898E-1
7.171E-1
 4 20
22 GO:1903020 positive regulation of glycoprotein metabolic process 1.760E-4 3.259E-2
2.898E-1
7.171E-1
 4 20
23 GO:0044334 canonical Wnt signaling pathway involved in positive regulation of epithelial to mesenchymal transition 2.104E-4 3.503E-2
3.114E-1
8.576E-1
 2 2
24 GO:0031331 positive regulation of cellular catabolic process 2.106E-4 3.503E-2
3.114E-1
8.581E-1
 15 352
25 GO:2000757 negative regulation of peptidyl-lysine acetylation 2.149E-4 3.503E-2
3.114E-1
8.757E-1
 4 21
26 GO:0016331 morphogenesis of embryonic epithelium 2.269E-4 3.556E-2
3.161E-1
9.244E-1
 10 173
27 GO:2000794 regulation of epithelial cell proliferation involved in lung morphogenesis 2.390E-4 3.607E-2
3.207E-1
9.740E-1
 3 9
28 GO:0002902 regulation of B cell apoptotic process 2.597E-4 3.670E-2
3.263E-1
1.000E0
 4 22
29 GO:0043488 regulation of mRNA stability 2.612E-4 3.670E-2
3.263E-1
1.000E0
 9 144
30 GO:0032922 circadian regulation of gene expression 2.772E-4 3.765E-2
3.347E-1
1.000E0
 6 62
31 GO:0031056 regulation of histone modification 3.201E-4 4.208E-2
3.741E-1
1.000E0
 9 148
32 GO:0043487 regulation of RNA stability 3.364E-4 4.229E-2
3.759E-1
1.000E0
 9 149
33 GO:0016574 histone ubiquitination 3.424E-4 4.229E-2
3.759E-1
1.000E0
 5 42
34 GO:1901984 negative regulation of protein acetylation 3.687E-4 4.350E-2
3.867E-1
1.000E0
 4 24
35 GO:0031057 negative regulation of histone modification 3.829E-4 4.350E-2
3.867E-1
1.000E0
 5 43
36 GO:0021915 neural tube development 4.048E-4 4.350E-2
3.867E-1
1.000E0
 10 186
37 GO:0010769 regulation of cell morphogenesis involved in differentiation 4.123E-4 4.350E-2
3.867E-1
1.000E0
 15 375
38 GO:0060425 lung morphogenesis 4.235E-4 4.350E-2
3.867E-1
1.000E0
 6 67
39 GO:0060612 adipose tissue development 4.270E-4 4.350E-2
3.867E-1
1.000E0
 5 44
40 GO:0061028 establishment of endothelial barrier 4.270E-4 4.350E-2
3.867E-1
1.000E0
 5 44
Show 35 more annotations

3: GO: Cellular Component [Display Chart] 439 annotations before applied cutoff / 19172 genes in category

No results to display

4: Human Phenotype [Display Chart] 718 annotations before applied cutoff / 4410 genes in category

ID Name Source pValue FDR B&H FDR B&Y Bonferroni Genes from Input Genes in Annotation
1 HP:0004325 Decreased body weight {has synonym type="layperson"} 2.827E-5 2.030E-2
1.452E-1
 2.030E-2 5 35
2 HP:0000151 Aplasia of the uterus 1.764E-4 3.973E-2
2.843E-1
1.266E-1
 3 11
3 HP:0000218 High palate {has synonym type="layperson"} 1.819E-4 3.973E-2
2.843E-1
1.306E-1
 10 243
4 HP:0001028 Hemangioma 2.214E-4 3.973E-2
2.843E-1
1.589E-1
 4 29
5 HP:0006740 Transitional cell carcinoma of the bladder 3.274E-4 4.701E-2
3.363E-1
2.351E-1
 4 32

5: Mouse Phenotype [Display Chart] 3611 annotations before applied cutoff / 9299 genes in category

ID Name Source pValue FDR B&H FDR B&Y Bonferroni Genes from Input Genes in Annotation
1 MP:0003232 abnormal forebrain development 1.317E-5 4.755E-2
4.170E-1
 4.755E-2 15 246
2 MP:0010802 abnormal intestinal enteroendocrine cell morphology 4.604E-5 4.830E-2
4.236E-1
1.663E-1
 4 13
3 MP:0000172 abnormal bone marrow cell number 5.553E-5 4.830E-2
4.236E-1
2.005E-1
 13 215
4 MP:0010313 increased osteoma incidence 8.589E-5 4.830E-2
4.236E-1
3.102E-1
 3 6
5 MP:0002196 absent corpus callosum 1.147E-4 4.830E-2
4.236E-1
4.142E-1
 6 47
6 MP:0000780 abnormal corpus callosum morphology 1.331E-4 4.830E-2
4.236E-1
4.808E-1
 10 144
7 MP:0010318 increased salivary gland tumor incidence 1.455E-4 4.830E-2
4.236E-1
5.255E-1
 4 17
8 MP:0001025 abnormal sympathetic neuron morphology 1.455E-4 4.830E-2
4.236E-1
5.255E-1
 4 17
9 MP:0002751 abnormal autonomic nervous system morphology 1.460E-4 4.830E-2
4.236E-1
5.273E-1
 8 93
10 MP:0010314 increased neurofibroma incidence 1.485E-4 4.830E-2
4.236E-1
5.362E-1
 3 7
11 MP:0002030 increased neurofibrosarcoma incidence 1.485E-4 4.830E-2
4.236E-1
5.362E-1
 3 7
12 MP:0008219 abnormal dorsal telencephalic commissure morphology 1.670E-4 4.830E-2
4.236E-1
6.029E-1
 10 148
13 MP:0004906 enlarged uterus 2.204E-4 4.830E-2
4.236E-1
7.958E-1
 5 34
14 MP:0004902 abnormal uterus size 2.258E-4 4.830E-2
4.236E-1
8.153E-1
 8 99
15 MP:0004187 cardia bifida 2.310E-4 4.830E-2
4.236E-1
8.341E-1
 4 19
16 MP:0004868 increased endometrial carcinoma incidence 2.347E-4 4.830E-2
4.236E-1
8.475E-1
 3 8
17 MP:0012570 increased mammary gland tumor incidence in breeding females 2.725E-4 4.830E-2
4.236E-1
9.840E-1
 2 2
18 MP:0000287 heart valve hypoplasia 2.725E-4 4.830E-2
4.236E-1
9.840E-1
 2 2
19 MP:0008490 enlarged dorsal root ganglion 2.725E-4 4.830E-2
4.236E-1
9.840E-1
 2 2
20 MP:0004896 abnormal endometrium morphology 2.777E-4 4.830E-2
4.236E-1
1.000E0
 6 55
21 MP:0004808 abnormal hematopoietic stem cell morphology 3.148E-4 4.830E-2
4.236E-1
1.000E0
 10 160
22 MP:0009222 increased uterus tumor incidence 3.476E-4 4.830E-2
4.236E-1
1.000E0
 4 21
23 MP:0004141 abnormal enteroendocrine cell morphology 3.476E-4 4.830E-2
4.236E-1
1.000E0
 4 21
24 MP:0012416 decreased gland tumor incidence 3.476E-4 4.830E-2
4.236E-1
1.000E0
 4 21
25 MP:0009284 abnormal sympathetic neuron innervation pattern 3.478E-4 4.830E-2
4.236E-1
1.000E0
 3 9
26 MP:0000934 abnormal telencephalon development 3.478E-4 4.830E-2
4.236E-1
1.000E0
 10 162
Show 21 more annotations

6: Domain [Display Chart] 1394 annotations before applied cutoff / 18735 genes in category

ID Name Source pValue FDR B&H FDR B&Y Bonferroni Genes from Input Genes in Annotation
1 PF03556 Cullin binding Pfam 3.061E-5 1.067E-2
8.339E-2
 4.267E-2 3 5
2 PS51229 DCUN1 PROSITE 3.061E-5 1.067E-2
8.339E-2
 4.267E-2 3 5
3 IPR005176 PONY dom InterPro 3.061E-5 1.067E-2
8.339E-2
 4.267E-2 3 5
4 IPR014764 DCN-prot InterPro 3.061E-5 1.067E-2
8.339E-2
 4.267E-2 3 5

7: Pathway [Display Chart] 1156 annotations before applied cutoff / 10916 genes in category

No results to display

8: Pubmed [Display Chart] 43244 annotations before applied cutoff / 51853 genes in category

ID Name Source pValue FDR B&H FDR B&Y Bonferroni Genes from Input Genes in Annotation
1 21903422 Mapping a dynamic innate immunity protein interaction network regulating type I interferon production. Pubmed 6.154E-13 2.661E-8 2.994E-7 2.661E-8 17 294
2 23752268 The functional interactome landscape of the human histone deacetylase family. Pubmed 5.176E-12 1.119E-7 1.259E-6 2.238E-7 16 287
3 25515538 A systems-wide screen identifies substrates of the SCFÃ?TrCP ubiquitin ligase. Pubmed 3.955E-11 5.700E-7 6.414E-6 1.710E-6 14 232
4 21963094 Global identification of modular cullin-RING ligase substrates. Pubmed 2.802E-10 3.030E-6 3.409E-5 1.212E-5 12 178
5 25900982 BioID-based Identification of Skp Cullin F-box (SCF)Ã?-TrCP1/2 E3 Ligase Substrates. Pubmed 3.589E-10 3.104E-6 3.492E-5 1.552E-5 13 226
6 21139048 Mass spectrometric analysis of lysine ubiquitylation reveals promiscuity at site level. Pubmed 5.217E-10 3.760E-6 4.231E-5 2.256E-5 13 233
7 25147182 Quantitative Lys-¿-Gly-Gly (diGly) proteomics coupled with inducible RNAi reveals ubiquitin-mediated proteolysis of DNA damage-inducible transcript 4 (DDIT4) by the E3 ligase HUWE1. Pubmed 7.182E-10 4.437E-6 4.992E-5 3.106E-5 16 401
8 21906983 Systematic and quantitative assessment of the ubiquitin-modified proteome. Pubmed 1.578E-9 8.458E-6 9.517E-5 6.825E-5 12 207
9 21890473 A proteome-wide, quantitative survey of in vivo ubiquitylation sites reveals widespread regulatory roles. Pubmed 1.760E-9 8.458E-6 9.517E-5 7.612E-5 12 209
10 27107012 Pooled-matrix protein interaction screens using Barcode Fusion Genetics. Pubmed 1.961E-9 8.480E-6 9.541E-5 8.480E-5 12 211
11 23398456 The P-body component USP52/PAN2 is a novel regulator of HIF1A mRNA stability. Pubmed 3.601E-9 1.416E-5 1.593E-4 1.557E-4 14 328
12 26350900 The E3 ligase RNF43 inhibits Wnt signaling downstream of mutated Ã?-catenin by sequestering TCF4 to the nuclear membrane. Pubmed 3.968E-9 1.430E-5 1.609E-4 1.716E-4 4 5
13 25852190 Integrative analysis of kinase networks in TRAIL-induced apoptosis provides a source of potential targets for combination therapy. Pubmed 5.869E-9 1.952E-5 2.197E-4 2.538E-4 15 401
14 20936779 A human MAP kinase interactome. Pubmed 1.097E-8 3.388E-5 3.812E-4 4.743E-4 16 486
15 18660489:gr Multiple genetic variants along candidate pathways influence plasma high-density lipoprotein cholesterol concentrations. GeneRIF 1.313E-8 3.550E-5 3.994E-4 5.680E-4 12 250
16 18660489 Multiple genetic variants along candidate pathways influence plasma high-density lipoprotein cholesterol concentrations. Pubmed 1.313E-8 3.550E-5 3.994E-4 5.680E-4 12 250
17 24255178 Protein interaction network of the mammalian Hippo pathway reveals mechanisms of kinase-phosphatase interactions. Pubmed 2.401E-8 6.108E-5 6.873E-4 1.038E-3 15 446
18 24366813 Interaction proteome of human Hippo signaling: modular control of the co-activator YAP1. Pubmed 3.071E-8 7.378E-5 8.301E-4 1.328E-3 12 270
19 22190034 Global landscape of HIV-human protein complexes. Pubmed 3.304E-8 7.519E-5 8.461E-4 1.429E-3 15 457
20 23667531 The SOX2-interactome in brain cancer cells identifies the requirement of MSI2 and USP9X for the growth of brain tumor cells. Pubmed 4.943E-8 1.069E-4 1.203E-3 2.137E-3 12 282
21 15525529 The APC tumor suppressor binds to C-terminal binding protein to divert nuclear beta-catenin from TCF. Pubmed 5.485E-8 1.130E-4 1.271E-3 2.372E-3 4 8
22 26549023 The scaffold protein KSR1, a novel therapeutic target for the treatment of Merlin-deficient tumors. Pubmed 6.900E-8 1.308E-4 1.472E-3 2.984E-3 13 351
23 22505724 Methods for quantification of in vivo changes in protein ubiquitination following proteasome and deubiquitinase inhibition. Pubmed 6.957E-8 1.308E-4 1.472E-3 3.008E-3 9 139
24 21987572 Ubiquitin ligase substrate identification through quantitative proteomics at both the protein and peptide levels. Pubmed 7.294E-8 1.314E-4 1.479E-3 3.154E-3 8 100
25 26641092 The Activation-Induced Assembly of an RNA/Protein Interactome Centered on the Splicing Factor U2AF2 Regulates Gene Expression in Human CD4 T Cells. Pubmed 8.161E-8 1.412E-4 1.588E-3 3.529E-3 11 239
26 22365833 Dynamic protein-protein interaction wiring of the human spliceosome. Pubmed 1.288E-7 1.574E-4 1.771E-3 5.569E-3 10 197
27 21613373:gr Evaluation of serum lipid concentrations and genetic variants at high-density lipoprotein metabolism loci and TIMP3 in age-related macular degeneration. GeneRIF 1.508E-7 1.574E-4 1.771E-3 6.522E-3 3 3
28 22231735:gr Sox4 functions as a positive regulator of Ã?-catenin signaling through upregulation of TCF4 during morular differentiation of endometrial carcinomas. GeneRIF 1.508E-7 1.574E-4 1.771E-3 6.522E-3 3 3
29 11713476 Structure of a human Tcf4-beta-catenin complex. Pubmed 1.508E-7 1.574E-4 1.771E-3 6.522E-3 3 3
30 18335551:gr Utility of thin-layer preparations in endometrial cytology: immunocytochemical expression of PTEN, beta-catenin and p53 for benign endometrial lesions. GeneRIF 1.508E-7 1.574E-4 1.771E-3 6.522E-3 3 3
31 22231735 Sox4 functions as a positive regulator of Ã?-catenin signaling through upregulation of TCF4 during morular differentiation of endometrial carcinomas. Pubmed 1.508E-7 1.574E-4 1.771E-3 6.522E-3 3 3
32 23269799 B cells in chronically hepatitis C virus-infected individuals lack a virus-induced mutation signature in the TP53, CTNNB1, and BCL6 genes. Pubmed 1.508E-7 1.574E-4 1.771E-3 6.522E-3 3 3
33 17504383:gr The prognostic value of PTEN, p53, and beta-catenin in endometrial carcinoma: a prospective immunocytochemical study. GeneRIF 1.508E-7 1.574E-4 1.771E-3 6.522E-3 3 3
34 17504383 The prognostic value of PTEN, p53, and beta-catenin in endometrial carcinoma: a prospective immunocytochemical study. Pubmed 1.508E-7 1.574E-4 1.771E-3 6.522E-3 3 3
35 19661141:gr Increased tissue factor expression is associated with reduced survival in non-small cell lung cancer and with mutations of TP53 and PTEN. GeneRIF 1.508E-7 1.574E-4 1.771E-3 6.522E-3 3 3
36 23269799:gr B cells in chronically hepatitis C virus-infected individuals lack a virus-induced mutation signature in the TP53, CTNNB1, and BCL6 genes. GeneRIF 1.508E-7 1.574E-4 1.771E-3 6.522E-3 3 3
37 21613373 Evaluation of serum lipid concentrations and genetic variants at high-density lipoprotein metabolism loci and TIMP3 in age-related macular degeneration. Pubmed 1.508E-7 1.574E-4 1.771E-3 6.522E-3 3 3
38 22156527 Role of Ã?-catenin and TCF/LEF family members in transcriptional activity of HIV in astrocytes. Pubmed 1.508E-7 1.574E-4 1.771E-3 6.522E-3 3 3
39 24556061 High concordance of molecular tumor alterations between pre-operative curettage and hysterectomy specimens in patients with endometrial carcinoma. Pubmed 1.508E-7 1.574E-4 1.771E-3 6.522E-3 3 3
40 18335551 Utility of thin-layer preparations in endometrial cytology: immunocytochemical expression of PTEN, beta-catenin and p53 for benign endometrial lesions. Pubmed 1.508E-7 1.574E-4 1.771E-3 6.522E-3 3 3
41 19661141 Increased tissue factor expression is associated with reduced survival in non-small cell lung cancer and with mutations of TP53 and PTEN. Pubmed 1.508E-7 1.574E-4 1.771E-3 6.522E-3 3 3
42 16196087 Large-scale analysis of the human ubiquitin-related proteome. Pubmed 1.529E-7 1.574E-4 1.771E-3 6.612E-3 12 313
43 24797263 Proteomic analysis of the epidermal growth factor receptor (EGFR) interactome and post-translational modifications associated with receptor endocytosis in response to EGF and stress. Pubmed 2.142E-7 2.154E-4 2.424E-3 9.262E-3 12 323
44 17643375 Systematic analysis of the protein interaction network for the human transcription machinery reveals the identity of the 7SK capping enzyme. Pubmed 2.310E-7 2.270E-4 2.554E-3 9.988E-3 13 390
45 17875931 Sox17 and Sox4 differentially regulate beta-catenin/T-cell factor activity and proliferation of colon carcinoma cells. Pubmed 2.553E-7 2.454E-4 2.761E-3 1.104E-2 4 11
46 23000965 Systems-wide analysis of ubiquitylation dynamics reveals a key role for PAF15 ubiquitylation in DNA-damage bypass. Pubmed 3.168E-7 2.978E-4 3.351E-3 1.370E-2 9 166
47 23084401 The cellular EJC interactome reveals higher-order mRNP structure and an EJC-SR protein nexus. Pubmed 3.686E-7 3.331E-4 3.748E-3 1.594E-2 9 169
48 24332808 PRP19 transforms into a sensor of RPA-ssDNA after DNA damage and drives ATR activation via a ubiquitin-mediated circuitry. Pubmed 3.697E-7 3.331E-4 3.748E-3 1.599E-2 12 340
49 24816145 A COFRADIC protocol to study protein ubiquitination. Pubmed 4.070E-7 3.592E-4 4.042E-3 1.760E-2 9 171
50 23184937 Deubiquitinase FAM/USP9X interacts with the E3 ubiquitin ligase SMURF1 protein and protects it from ligase activity-dependent self-degradation. Pubmed 4.275E-7 3.697E-4 4.160E-3 1.849E-2 9 172
Show 45 more annotations

9: Interaction [Display Chart] 5689 annotations before applied cutoff / 16534 genes in category

ID Name Source pValue FDR B&H FDR B&Y Bonferroni Genes from Input Genes in Annotation
1 int:UNK UNK interactions 1.976E-8 1.124E-4 1.037E-3 1.124E-4 21 296
2 int:FBXW11 FBXW11 interactions 2.844E-7 8.089E-4 7.461E-3 1.618E-3 22 377
3 int:TCTN3 TCTN3 interactions 5.179E-6 9.820E-3
9.058E-2
 2.946E-2 18 317
4 int:PON2 PON2 interactions 3.379E-5 4.806E-2
4.433E-1
1.922E-1
 8 76

10: Cytoband [Display Chart] 233 annotations before applied cutoff / 34661 genes in category

No results to display

11: Transcription Factor Binding Site [Display Chart] 552 annotations before applied cutoff / 9770 genes in category

ID Name Source pValue FDR B&H FDR B&Y Bonferroni Genes from Input Genes in Annotation
1 TTAYRTAA V$E4BP4 01 TTAYRTAA V$E4BP4 01 1.141E-5 6.300E-3 4.342E-2 6.300E-3 14 209
2 V$PAX4 04 V$PAX4 04 3.302E-5 7.208E-3 4.967E-2 1.823E-2 12 172
3 V$E4BP4 01 V$E4BP4 01 3.917E-5 7.208E-3 4.967E-2 2.162E-2 12 175
4 V$SOX9 B1 V$SOX9 B1 9.635E-5 1.224E-2
8.437E-2
5.318E-2
 12 192
5 V$CREBP1 01 V$CREBP1 01 1.109E-4 1.224E-2
8.437E-2
6.121E-2
 10 138
6 V$CEBPA 01 V$CEBPA 01 1.354E-4 1.246E-2
8.587E-2
7.476E-2
 12 199
Show 1 more annotation

12: Gene Family [Display Chart] 131 annotations before applied cutoff / 18194 genes in category

ID Name Source pValue FDR B&H FDR B&Y Bonferroni Genes from Input Genes in Annotation
1 725 RNA binding motif containing genenames.org 2.658E-4 2.473E-2
1.349E-1
 3.482E-2 9 213
2 418 AT-rich interaction domain containing genenames.org 3.906E-4 2.473E-2
1.349E-1
5.116E-2
 3 15
3 684 Zinc fingers|Zinc fingers PARP-type|Poly(ADP-ribose) polymerases genenames.org 5.753E-4 2.473E-2
1.349E-1
7.536E-2
 3 17
4 409 Armadillo repeat containing|Protein phosphatase 1 regulatory subunits genenames.org 8.287E-4 2.473E-2
1.349E-1
1.086E-1
 4 43
5 902 C2 tensin-type domain containing|PTEN protein phosphatases|Phosphoinositide phosphatases genenames.org 9.440E-4 2.473E-2
1.349E-1
1.237E-1
 2 5
6 984 SUMO specific peptidases genenames.org 1.957E-3 4.245E-2
2.316E-1
2.563E-1
 2 7
7 553 Fatty acid desaturases genenames.org 2.592E-3 4.245E-2
2.316E-1
3.396E-1
 2 8
8 837 DNAJ (HSP40) heat shock proteins|C2 tensin-type domain containing genenames.org 2.592E-3 4.245E-2
2.316E-1
3.396E-1
 2 8
Show 3 more annotations

13: Coexpression [Display Chart] 6793 annotations before applied cutoff / 21867 genes in category

ID Name Source pValue FDR B&H FDR B&Y Bonferroni Genes from Input Genes in Annotation
1 M2239 Genes down-regulated upon overexpression of PARVB [GeneID=29780] in MDA-MB-231 cells (breast cancer) cultured in 3D collagen I and 3D Matrigel only. MSigDB C2: CGP Curated Gene Sets (v5.1) 3.831E-17 2.603E-13 2.447E-12 2.603E-13 30 334
2 GSE19888 ADENOSINE A3R INH PRETREAT AND ACT BY A3R VS A3R INH AND TCELL MEMBRANES ACT MAST CELL UP Genes up-regulated in HMC-1 (mast leukemia) cells incubated with the peptide ALL1 followed by treatment with: Cl-IB-MECA [PubChem=3035850] versus T cell membranes. MSigDB C7: Immunologic Signatures (v5.1) 4.588E-9 1.163E-5 1.093E-4 3.116E-5 16 197
3 M2521 Loci bound by both isoforms (a and b) of SALL4 [GeneID=57167] in ES cells (embryonic stem). MSigDB C2: CGP Curated Gene Sets (v5.1) 5.136E-9 1.163E-5 1.093E-4 3.489E-5 17 227
4 M8880 Genes down-regulated during pubertal mammary gland development between week 5 and 6. MSigDB C2: CGP Curated Gene Sets (v5.1) 2.065E-8 3.507E-5 3.297E-4 1.403E-4 13 137
5 M5275 Genes up-regulated in blood samples from bladder cancer patients. MSigDB C2: CGP Curated Gene Sets (v5.1) 5.187E-8 6.016E-5 5.655E-4 3.524E-4 21 404
6 M12591 Genes up-regulated by 3 h of euglycemic hyperinsulinemic clamp in the vastus lateralis muscle of healthy lean subjects. MSigDB C2: CGP Curated Gene Sets (v5.1) 5.314E-8 6.016E-5 5.655E-4 3.610E-4 22 442
7 M1613 Transcripts depleted in pseudopodia of NIH/3T3 cells (fibroblast) in response to the chemotactic migration stimulus by lysophosphatidic acid (LPA) [PubChem=3988]. MSigDB C2: CGP Curated Gene Sets (v5.1) 9.518E-8 9.237E-5 8.683E-4 6.466E-4 22 457
8 M4665 Genes down-regulated in glomeruli of kidneys from patients with diabetic nephropathy (type 2 diabetes mellitus). MSigDB C2: CGP Curated Gene Sets (v5.1) 1.728E-7 1.323E-4 1.244E-3 1.174E-3 21 434
9 M2855 Genes up-regulated in NOMO-1 cells (AML) after knockdown of STK33 [Gene ID=65975] by RNAi. MSigDB C6: Oncogenic Signatures (v5.1) 1.955E-7 1.323E-4 1.244E-3 1.328E-3 17 291
10 M12029 Genes selected in supervised analyses to discriminate cells expressing activated HRAS [GeneID=3265] oncogene from control cells expressing GFP. MSigDB C2: CGP Curated Gene Sets (v5.1) 2.352E-7 1.323E-4 1.244E-3 1.598E-3 16 261
11 GSE15624 3H VS 6H HALOFUGINONE TREATED CD4 TCELL DN Genes down-regulated in CD4 [GeneID=920] T cells treated with halofuginone [PubChem=400772]: 3h versus 6h. MSigDB C7: Immunologic Signatures (v5.1) 2.419E-7 1.323E-4 1.244E-3 1.643E-3 12 141
12 M13522 Common down-regulated transcripts in fibroblasts expressing either XP/CS or TDD mutant forms of ERCC3 [GeneID=2071], after UVC irradiation. MSigDB C2: CGP Curated Gene Sets (v5.1) 2.467E-7 1.323E-4 1.244E-3 1.676E-3 22 483
13 M10091 Genes down-regulated in mucinous ovarian carcinoma tumors of low malignant potential (LMP) compared to normal ovarian surface epithelium tissue. MSigDB C2: CGP Curated Gene Sets (v5.1) 2.565E-7 1.323E-4 1.244E-3 1.742E-3 14 199
14 M5777 Genes up-regulated in comparison of peripheral blood mononuclear cells (PBMC) from healthy donors versus PBMCs from patients with type 1 diabetes at 1 month after the diagnosis. MSigDB C7: Immunologic Signatures (v5.1) 2.727E-7 1.323E-4 1.244E-3 1.853E-3 14 200
15 M8617 Potential direct target genes for MIR34A [GeneID=407040] microRNA in IMR32 cells (neuroblastoma). MSigDB C2: CGP Curated Gene Sets (v5.1) 3.535E-7 1.601E-4 1.505E-3 2.401E-3 12 146
16 M10355 Genes up-regulated in MCV152 cells (ovarian cancer) treated with follicle stimulating hormone (FSH). MSigDB C2: CGP Curated Gene Sets (v5.1) 3.852E-7 1.616E-4 1.519E-3 2.617E-3 9 74
17 M14973 Genes up-regulated in U2OS cells (osteosarcoma) upon knockdown of HDAC1 [GeneID=3065] by RNAi. MSigDB C2: CGP Curated Gene Sets (v5.1) 4.044E-7 1.616E-4 1.519E-3 2.747E-3 21 457
18 M13630 Selected genes down-regulated in WS1 (fibroblast) in response to irradiation with high dose UV-C. MSigDB C2: CGP Curated Gene Sets (v5.1) 5.212E-7 1.967E-4 1.849E-3 3.541E-3 17 312
19 M7514 Genes down-regulated in NIH3T3 cells (fibroblasts) transformed by expression of contitutively active (Q63L) form of RHOA [GeneID=387] off plasmid vector. MSigDB C2: CGP Curated Gene Sets (v5.1) 7.134E-7 2.476E-4 2.328E-3 4.846E-3 19 394
20 M16975 Up-regulated genes in peripheral zone of human pancreatic cancer growing in the pancreas of nude mice compared to that of the tumor from the central zone. MSigDB C2: CGP Curated Gene Sets (v5.1) 7.291E-7 2.476E-4 2.328E-3 4.953E-3 16 284
21 M8976 Down-regulated genes discriminating between MSI (microsatellite instability) and MSS (microsatellite stability) colon cancers. MSigDB C2: CGP Curated Gene Sets (v5.1) 8.419E-7 2.723E-4 2.560E-3 5.719E-3 9 81
22 M2196 Genes significantly de-regulated (p < 0.05) by MIR21 [GeneID=406991] in A172 cells (glioma). MSigDB C2: CGP Curated Gene Sets (v5.1) 9.182E-7 2.835E-4 2.665E-3 6.237E-3 16 289
23 M3782 Genes down-regulated in ST1 cells (adult T-cell leukemia, ATL) after knockdown of FRA2 [GeneID=2355] by RNAi. MSigDB C2: CGP Curated Gene Sets (v5.1) 1.033E-6 3.052E-4 2.869E-3 7.020E-3 7 43
24 GSE23925 DARK ZONE VS NAIVE BCELL UP Genes up-regulated in B cells: dark zone versus naïve. MSigDB C7: Immunologic Signatures (v5.1) 1.685E-6 4.580E-4 4.305E-3 1.145E-2 13 200
25 GSE43863 TFH VS LY6C LOW CXCR5NEG EFFECTOR CD4 TCELL UP Genes up-regulated in CD4 [GeneID=920] SMARTA effector T cells during acute infection of LCMV: follicular helper (Tfh) versus Ly6c low CXCR5- [GeneID=643]. MSigDB C7: Immunologic Signatures (v5.1) 1.685E-6 4.580E-4 4.305E-3 1.145E-2 13 200
26 M18441 Genes down-regulated in samples with systolic heart failure compared to normal hearts. MSigDB C2: CGP Curated Gene Sets (v5.1) 2.541E-6 6.638E-4 6.240E-3 1.726E-2 14 241
27 M2858 Genes up-regulated in NOMO-1 and SKM-1 cells (AML) after knockdown of STK33 [Gene ID=65975] by RNAi. MSigDB C6: Oncogenic Signatures (v5.1) 4.269E-6 1.074E-3 1.010E-2 2.900E-2 15 288
28 M12676 Class NT (non-tolerizeable) genes: induced during the first LPS stimulation and induced at equal or greater degree in tolerant macrophages. MSigDB C2: CGP Curated Gene Sets (v5.1) 5.062E-6 1.228E-3 1.154E-2 3.438E-2 18 409
29 M4735 Genes up-regulated in MCF7 cells (breast cancer) engineered to conditionally express LMO4 [GeneID=8543] by a Tet Off system. MSigDB C2: CGP Curated Gene Sets (v5.1) 5.284E-6 1.238E-3 1.164E-2 3.589E-2 17 370
30 GSE40274 CTRL VS GATA1 TRANSDUCED ACTIVATED CD4 TCELL DN Genes down-regulated in CD4 T conv: control versus over-expression of GATA1 [GeneID=2623]. MSigDB C7: Immunologic Signatures (v5.1) 5.545E-6 1.256E-3 1.180E-2 3.767E-2 11 158
31 M2155 Genes up-regulated during pubertal mammary gland development between week 6 and 7. MSigDB C2: CGP Curated Gene Sets (v5.1) 8.241E-6 1.418E-3 1.334E-2
5.598E-2
 12 197
32 M15150 Genes up-regulated in cancer stem cells isolated from mammary tumors compared to the non-tumorigenic cells. MSigDB C2: CGP Curated Gene Sets (v5.1) 8.556E-6 1.418E-3 1.334E-2
5.812E-2
 18 425
33 M6711 Genes down-regulated in endothelial cells: untreated versus IFNG [GeneID=3458]. MSigDB C7: Immunologic Signatures (v5.1) 9.130E-6 1.418E-3 1.334E-2
6.202E-2
 12 199
34 M3347 Genes down-regulated in comparison of dendritic cells (DC) before and 4 h after LPS (TLR4 agonist) stimulation. MSigDB C7: Immunologic Signatures (v5.1) 9.130E-6 1.418E-3 1.334E-2
6.202E-2
 12 199
35 GSE41867 DAY8 VS DAY15 LCMV CLONE13 EFFECTOR CD8 TCELL UP Genes up-regulated in CD8 T effector cells during chronic infection with LCMV-Clone 13: day 8 versus day 15. MSigDB C7: Immunologic Signatures (v5.1) 9.606E-6 1.418E-3 1.334E-2
6.525E-2
 12 200
36 GSE40277 EOS AND LEF1 TRANSDUCED VS CTRL CD4 TCELL UP Genes up-regulated in CD4 [GeneID=920] T conv: over-expressing IKZF4 and LEF1 [GeneID=64375;52276] versus control. MSigDB C7: Immunologic Signatures (v5.1) 9.606E-6 1.418E-3 1.334E-2
6.525E-2
 12 200
37 GSE34006 A2AR KO VS A2AR AGONIST TREATED TREG UP Genes up-regulated in T reg: untreated ADORA2A [GeneID=135] knockout versus wildtype treated by ZM 241385 [PubChem=176407]. MSigDB C7: Immunologic Signatures (v5.1) 9.606E-6 1.418E-3 1.334E-2
6.525E-2
 12 200
38 GSE43863 NAIVE VS MEMORY TFH CD4 TCELL D150 LCMV UP Genes up-regulated in CD4 [GeneID=920] SMARTA T cells: naïve versus memory follicular helper (Tfh). MSigDB C7: Immunologic Signatures (v5.1) 9.606E-6 1.418E-3 1.334E-2
6.525E-2
 12 200
39 M3671 Genes down-regulated in comparison of regulatory T cell (Treg) from uninfected mice versus T effector cells from uninfected mice. MSigDB C7: Immunologic Signatures (v5.1) 9.606E-6 1.418E-3 1.334E-2
6.525E-2
 12 200
40 M5856 Genes up-regulated in comparison of monocytes treated with 5000 ng/ml LPS (TLR4 agonist) versus monocytes treated with anti-TREM1 [GeneID=54210]. MSigDB C7: Immunologic Signatures (v5.1) 9.606E-6 1.418E-3 1.334E-2
6.525E-2
 12 200
41 M5779 Genes up-regulated in comparison of peripheral blood mononuclear cells (PBMC) from healthy donors versus PBMCs from patients with type 1 diabetes at 4 month after the diagnosis. MSigDB C7: Immunologic Signatures (v5.1) 9.606E-6 1.418E-3 1.334E-2
6.525E-2
 12 200
42 M6635 Genes up-regulated in bone marrow-derived macrophages with IL10 [GeneID=3486] knockout and 45 min of stimulation by: LPS versus IL6 [GeneID=3469] and LPS. MSigDB C7: Immunologic Signatures (v5.1) 9.606E-6 1.418E-3 1.334E-2
6.525E-2
 12 200
43 M4865 Genes up-regulated in comparison of NKT cells versus erythroblasts. MSigDB C7: Immunologic Signatures (v5.1) 9.606E-6 1.418E-3 1.334E-2
6.525E-2
 12 200
44 M3497 Genes down-regulated in comparison of unstimulated macrophage cells versus macrophage cells stimulated with LPS (TLR4 agonist) for 40 min. MSigDB C7: Immunologic Signatures (v5.1) 9.606E-6 1.418E-3 1.334E-2
6.525E-2
 12 200
45 M5859 Genes down-regulated in comparison of monocytes treated with 5000 ng/ml LPS (TLR4 agonist) versus monocytes treated with control IgG. MSigDB C7: Immunologic Signatures (v5.1) 9.606E-6 1.418E-3 1.334E-2
6.525E-2
 12 200
46 GSE21670 UNTREATED VS IL6 TREATED CD4 TCELL DN Genes down-regulated in CD4 [GeneID=920] T cells: medium versus IL6 [GeneID=3569]. MSigDB C7: Immunologic Signatures (v5.1) 9.606E-6 1.418E-3 1.334E-2
6.525E-2
 12 200
47 GSE10422 WT VS BAFF TRANSGENIC LN BCELL UP Genes up-regulated in wildtype B cells versus BAFF-transgenic (over-express TNFSF13B [GeneID=10673]) B cells from lymph node. MSigDB C7: Immunologic Signatures (v5.1) 1.054E-5 1.523E-3 1.432E-2
7.158E-2
 11 169
48 M2293 Genes down-regulated in ES (embryonic stem cells) with defficient SUZ12 [GeneID=23512]. MSigDB C2: CGP Curated Gene Sets (v5.1) 1.249E-5 1.767E-3 1.661E-2
8.483E-2
 15 315
49 M5793 Down-regulated genes in the canonical gene expression signature of the fibroblast core serum response (CSR) defined by the Stanford group. MSigDB C2: CGP Curated Gene Sets (v5.1) 1.496E-5 2.059E-3 1.936E-2
1.016E-1
 12 209
50 M5942 Genes down-regulated in response to ultraviolet (UV) radiation. MSigDB H: Hallmark Gene Sets (v5.1) 1.516E-5 2.059E-3 1.936E-2
1.030E-1
 10 144
Show 45 more annotations

14: Coexpression Atlas [Display Chart] 2906 annotations before applied cutoff / 20974 genes in category

ID Name Source pValue FDR B&H FDR B&Y Bonferroni Genes from Input Genes in Annotation
1 fetal replicating Top 500 Cluster 3 fetal replicating Top 500 Cluster 3 Brain Map - Barres 7.346E-28 2.135E-24 1.826E-23 2.135E-24 19 33
2 fetal replicating Top 500 All fetal replicating Top 500 All Brain Map - Barres 1.172E-26 1.703E-23 1.456E-22 3.405E-23 47 496
3 fetal quiescent Top 500 Cluster 1 fetal quiescent Top 500 Cluster 1 Brain Map - Barres 3.196E-16 3.096E-13 2.648E-12 9.288E-13 13 35
4 astrocytes Top 500 Cluster 0 astrocytes Top 500 Cluster 0 Brain Map - Barres 2.765E-14 2.009E-11 1.718E-10 8.034E-11 14 59
5 fetal quiescent Top 500 All fetal quiescent Top 500 All Brain Map - Barres 5.428E-13 2.884E-10 2.467E-9 1.577E-9 31 489
6 gudmap developingLowerUrinaryTract e14.5 bladder 1000 k5 DevelopingLowerUrinaryTract e14.5 bladder emap-30872 k-means-cluster#5 top-relative-expression-ranked 1000 Gudmap Mouse MOE430.2 5.955E-13 2.884E-10 2.467E-9 1.731E-9 28 397
7 astrocytes Top 500 All astrocytes Top 500 All Brain Map - Barres 4.331E-12 1.798E-9 1.538E-8 1.259E-8 30 496
8 gudmap developingGonad e11.5 testes and mesonephros 500 DevelopingGonad e11.5 testes and mesonephros emap-3226 top-relative-expression-ranked 500 Gudmap Mouse MOE430.2 1.631E-10 5.924E-8 5.066E-7 4.739E-7 26 435
9 gudmap developingGonad P2 testes 1000 k2 DevelopingGonad P2 testes emap-30171 k-means-cluster#2 top-relative-expression-ranked 1000 Gudmap Mouse MOE430.2 2.922E-10 9.434E-8 8.068E-7 8.490E-7 23 349
10 DevelopingLowerUrinaryTract e14.5 urogenital sinus emap-6689 k2 1000 DevelopingLowerUrinaryTract e14.5 urogenital sinus emap-6689 k-means-cluster#2 top-relative-expression-ranked 1000 Gudmap Mouse MOE430.2 5.818E-10 1.578E-7 1.350E-6 1.691E-6 22 330
11 gudmap developingGonad e18.5 testes 1000 k3 DevelopingGonad e18.5 testes emap-11164 k-means-cluster#3 top-relative-expression-ranked 1000 Gudmap Mouse MOE430.2 5.974E-10 1.578E-7 1.350E-6 1.736E-6 23 362
12 fetal replicating Top 500 Cluster 2 fetal replicating Top 500 Cluster 2 Brain Map - Barres 7.449E-10 1.804E-7 1.543E-6 2.165E-6 8 25
13 54Dp SubClass 54Dp 5 Top 500 Cluster 1 54Dp SubClass 54Dp 5 Top 500 Cluster 1 Brain Map - Allen iN 1.252E-9 2.798E-7 2.393E-6 3.638E-6 9 38
14 gudmap developingLowerUrinaryTract e14.5 urogenital sinus 1000 k4 DevelopingLowerUrinaryTract e14.5 urogenital sinus emap-5517 k-means-cluster#4 top-relative-expression-ranked 1000 Gudmap Mouse MOE430.2 1.003E-8 2.082E-6 1.781E-5 2.915E-5 22 385
15 OPC Top 500 Cluster 4 OPC Top 500 Cluster 4 Brain Map - Barres 1.390E-8 2.692E-6 2.302E-5 4.038E-5 9 49
16 fetal replicating Top 500 Cluster 4 fetal replicating Top 500 Cluster 4 Brain Map - Barres 2.862E-8 5.199E-6 4.446E-5 8.318E-5 9 53
17 oligodendrocytes Top 500 Cluster 1 oligodendrocytes Top 500 Cluster 1 Brain Map - Barres 4.461E-8 7.626E-6 6.522E-5 1.296E-4 8 40
18 54Dn SubClass 54Dn 1SK Top 500 All 54Dn SubClass 54Dn 1SK Top 500 All Brain Map - Allen iN 5.653E-8 9.127E-6 7.805E-5 1.643E-4 23 461
19 DevelopingLowerUrinaryTract e14.5 bladder emap-6668 k5 1000 DevelopingLowerUrinaryTract e14.5 bladder emap-6668 k-means-cluster#5 top-relative-expression-ranked 1000 Gudmap Mouse MOE430.2 1.115E-7 1.641E-5 1.404E-4 3.242E-4 14 178
20 54Dn SubClass 54Dn 1SK Top 500 Cluster 3 54Dn SubClass 54Dn 1SK Top 500 Cluster 3 Brain Map - Allen iN 1.130E-7 1.641E-5 1.404E-4 3.283E-4 10 81
21 OPC Top 500 All OPC Top 500 All Brain Map - Barres 1.951E-7 2.700E-5 2.309E-4 5.670E-4 23 494
22 gudmap developingGonad e11.5 testes and mesonephros k3 500 DevelopingGonad e11.5 testes and mesonephros emap-3226 k-means-cluster#3 top-relative-expression-ranked 500 Gudmap Mouse MOE430.2 2.428E-7 3.207E-5 2.743E-4 7.055E-4 12 135
23 gudmap developingGonad e14.5 testes 1000 k5 DevelopingGonad e14.5 testes emap-6710 k-means-cluster#5 top-relative-expression-ranked 1000 Gudmap Mouse MOE430.2 2.983E-7 3.769E-5 3.224E-4 8.670E-4 21 429
24 neurons SubClass GLRA2-hi Top 500 Cluster 4 neurons SubClass GLRA2-hi Top 500 Cluster 4 Brain Map - Barres 3.258E-7 3.851E-5 3.294E-4 9.467E-4 8 51
25 gudmap developingGonad e11.5 ovary + mesonephros k2 1000 DevelopingGonad e11.5 ovary + mesonephros emap-3226 k-means-cluster#2 top-relative-expression-ranked 1000 Gudmap Mouse MOE430.2 3.313E-7 3.851E-5 3.294E-4 9.628E-4 18 323
26 gudmap developingLowerUrinaryTract e14.5 bladder 500 k1 DevelopingLowerUrinaryTract e14.5 bladder emap-30872 k-means-cluster#1 top-relative-expression-ranked 500 Gudmap Mouse MOE430.2 4.759E-7 5.319E-5 4.549E-4 1.383E-3 15 231
27 DevelopingLowerUrinaryTract e14.5 urethra emap-30902 k3 1000 DevelopingLowerUrinaryTract e14.5 urethra emap-30902 k-means-cluster#3 top-relative-expression-ranked 1000 Gudmap Mouse MOE430.2 5.203E-7 5.600E-5 4.789E-4 1.512E-3 19 369
28 gudmap developingGonad e14.5 epididymis 500 DevelopingGonad e14.5 epididymis emap-29141 top-relative-expression-ranked 500 Gudmap Mouse MOE430.2 6.817E-7 7.053E-5 6.032E-4 1.981E-3 20 413
29 microglia Top 500 Cluster 0 microglia Top 500 Cluster 0 Brain Map - Barres 7.038E-7 7.053E-5 6.032E-4 2.045E-3 5 14
30 gudmap developingGonad e16.5 testes 1000 k3 DevelopingGonad e16.5 testes emap-8444 k-means-cluster#3 top-relative-expression-ranked 1000 Gudmap Mouse MOE430.2 7.480E-7 7.246E-5 6.197E-4 2.174E-3 19 378
31 endothelial SubClass DCN-hi Top 500 All endothelial SubClass DCN-hi Top 500 All Brain Map - Barres 7.923E-7 7.347E-5 6.283E-4 2.302E-3 22 495
32 gudmap developingGonad e12.5 testes k4 500 DevelopingGonad e12.5 testes emap-29069 k-means-cluster#4 top-relative-expression-ranked 500 Gudmap Mouse MOE430.2 8.148E-7 7.347E-5 6.283E-4 2.368E-3 15 241
33 OPC Top 500 Cluster 1 OPC Top 500 Cluster 1 Brain Map - Barres 8.343E-7 7.347E-5 6.283E-4 2.425E-3 7 40
34 oligodendrocytes Top 500 All oligodendrocytes Top 500 All Brain Map - Barres 8.760E-7 7.487E-5 6.403E-4 2.546E-3 22 498
35 endothelial SubClass DCN-hi Top 500 Cluster 4 endothelial SubClass DCN-hi Top 500 Cluster 4 Brain Map - Barres 1.503E-6 1.248E-4 1.067E-3 4.367E-3 5 16
36 gudmap developingGonad e11.5 testes 500 DevelopingGonad e11.5 testes emap-3226 top-relative-expression-ranked 500 Gudmap Mouse MOE430.2 1.631E-6 1.317E-4 1.126E-3 4.741E-3 20 437
37 gudmap developingGonad P2 testes 500 k3 DevelopingGonad P2 testes emap-30171 k-means-cluster#3 top-relative-expression-ranked 500 Gudmap Mouse MOE430.2 1.980E-6 1.555E-4 1.330E-3 5.753E-3 11 136
38 gudmap developingGonad e11.5 ovary + mesonephros 500 DevelopingGonad e11.5 ovary + mesonephros emap-3226 top-relative-expression-ranked 500 Gudmap Mouse MOE430.2 3.186E-6 2.437E-4 2.084E-3 9.259E-3 19 417
39 gudmap developingLowerUrinaryTract e14.5 Genital tubercle 1000 k1 DevelopingLowerUrinaryTract e14.5 Genital tubercle emap-6706 k-means-cluster#1 top-relative-expression-ranked 1000 Gudmap Mouse MOE430.2 4.476E-6 3.335E-4 2.852E-3 1.301E-2 13 209
40 Facebase RNAseq e9.5 Mandibular Arch 2500 K3 FacebaseRNAseq e9.5 Mandibular Arch top-relative-expression-ranked 2500 k-means-cluster#3 FaceBase_RNAseq 4.979E-6 3.618E-4 3.094E-3 1.447E-2 16 315
41 Lungmap Mouse e18.5 Epithelial (GSE52583) SubClass Bi-potential Top 500 All Mouse Lung E18.5 Epithelial Bi-potential top 500 Lungmap Mouse Single Cell (Lungmap.net) 7.376E-6 5.228E-4 4.471E-3 2.144E-2 18 402
42 Facebase RNAseq e10.5 Lateral Nasal Eminence 1000 K5 FacebaseRNAseq e10.5 Lateral Nasal Eminence top-relative-expression-ranked 1000 k-means-cluster#5 FaceBase_RNAseq 8.209E-6 5.680E-4 4.857E-3 2.385E-2 13 221
43 gudmap developingGonad e14.5 epididymis 1000 k4 DevelopingGonad e14.5 epididymis emap-29141 k-means-cluster#4 top-relative-expression-ranked 1000 Gudmap Mouse MOE430.2 8.511E-6 5.752E-4 4.919E-3 2.473E-2 14 256
44 DevelopingLowerUrinaryTract e14.5 urethra emap-30902 k5 500 DevelopingLowerUrinaryTract e14.5 urethra emap-30902 k-means-cluster#5 top-relative-expression-ranked 500 Gudmap Mouse MOE430.2 1.106E-5 7.300E-4 6.243E-3 3.213E-2 12 194
45 gudmap developingKidney e15.5 cortic collect duct 1000 k4 DevelopingKidney e15.5 cortic collect duct emap-28132 k-means-cluster#4 top-relative-expression-ranked 1000 Gudmap Mouse MOE430.2 1.130E-5 7.300E-4 6.243E-3 3.285E-2 17 375
46 gudmap dev gonad e11.5 M GonadVasMes Flk k1 1000 dev gonad e11.5 M GonadVasMes Flk k-means-cluster#1 top-relative-expression-ranked 1000 Gudmap Mouse ST 1.0 1.205E-5 7.612E-4 6.510E-3 3.502E-2 16 338
47 gudmap developingLowerUrinaryTract P1 bladder B 1000 k2 DevelopingLowerUrinaryTract P1 bladder B emap-30374 k-means-cluster#2 top-relative-expression-ranked 1000 Gudmap Mouse MOE430.2 1.297E-5 8.017E-4 6.856E-3 3.768E-2 17 379
48 fetal quiescent Top 500 Cluster 4 fetal quiescent Top 500 Cluster 4 Brain Map - Barres 1.342E-5 8.124E-4 6.948E-3 3.900E-2 9 108
49 gudmap developingLowerUrinaryTract e14.5 bladder 500 DevelopingLowerUrinaryTract e14.5 bladder emap-30872 top-relative-expression-ranked 500 Gudmap Mouse MOE430.2 1.378E-5 8.172E-4 6.989E-3 4.004E-2 18 421
50 endothelial SubClass DCN-hi Top 500 Cluster 0 endothelial SubClass DCN-hi Top 500 Cluster 0 Brain Map - Barres 1.658E-5 9.637E-4 8.242E-3 4.819E-2 5 25
Show 45 more annotations

15: Computational [Display Chart] 477 annotations before applied cutoff / 9399 genes in category

No results to display

16: MicroRNA [Display Chart] 1491 annotations before applied cutoff / 19844 genes in category

ID Name Source pValue FDR B&H FDR B&Y Bonferroni Genes from Input Genes in Annotation
1 hsa-miR-32:PITA hsa-miR-32:PITA TOP PITA 3.101E-14 3.287E-11 2.591E-10 4.624E-11 33 480
2 hsa-miR-363:PITA hsa-miR-363:PITA TOP PITA 4.409E-14 3.287E-11 2.591E-10 6.573E-11 33 486
3 hsa-miR-223:PITA hsa-miR-223:PITA TOP PITA 1.475E-13 5.744E-11 4.529E-10 2.199E-10 23 231
4 hsa-miR-25:PITA hsa-miR-25:PITA TOP PITA 2.697E-13 5.744E-11 4.529E-10 4.021E-10 32 487
5 hsa-miR-92a:PITA hsa-miR-92a:PITA TOP PITA 2.697E-13 5.744E-11 4.529E-10 4.021E-10 32 487
6 hsa-miR-367:PITA hsa-miR-367:PITA TOP PITA 2.697E-13 5.744E-11 4.529E-10 4.021E-10 32 487
7 hsa-miR-92b:PITA hsa-miR-92b:PITA TOP PITA 2.697E-13 5.744E-11 4.529E-10 4.021E-10 32 487
8 hsa-miR-323-3p:PITA hsa-miR-323-3p:PITA TOP PITA 7.502E-13 1.398E-10 1.102E-9 1.118E-9 28 384
9 hsa-miR-567:PITA hsa-miR-567:PITA TOP PITA 1.717E-12 2.845E-10 2.243E-9 2.561E-9 19 166
10 hsa-miR-340*:mirSVR highEffct hsa-miR-340*:mirSVR nonconserved highEffect-0.5 MicroRNA.org 3.196E-12 4.765E-10 3.757E-9 4.765E-9 27 378
11 hsa-miR-513b:PITA hsa-miR-513b:PITA TOP PITA 3.673E-12 4.978E-10 3.925E-9 5.476E-9 25 323
12 hsa-miR-129-5p:PITA hsa-miR-129-5p:PITA TOP PITA 8.040E-12 9.989E-10 7.876E-9 1.199E-8 30 487
13 hsa-miR-641:PITA hsa-miR-641:PITA TOP PITA 9.373E-12 1.075E-9 8.476E-9 1.397E-8 30 490
14 miR-101:PicTar miR-101:PicTar PicTar 1.135E-11 1.128E-9 8.894E-9 1.693E-8 28 430
15 TGAATGT,MIR-181C:MSigDB TGAATGT,MIR-181C:MSigDB MSigDB 1.362E-11 1.128E-9 8.894E-9 2.030E-8 29 465
16 TGAATGT,MIR-181A:MSigDB TGAATGT,MIR-181A:MSigDB MSigDB 1.362E-11 1.128E-9 8.894E-9 2.030E-8 29 465
17 TGAATGT,MIR-181B:MSigDB TGAATGT,MIR-181B:MSigDB MSigDB 1.362E-11 1.128E-9 8.894E-9 2.030E-8 29 465
18 TGAATGT,MIR-181D:MSigDB TGAATGT,MIR-181D:MSigDB MSigDB 1.362E-11 1.128E-9 8.894E-9 2.030E-8 29 465
19 hsa-miR-224:PITA hsa-miR-224:PITA TOP PITA 1.650E-11 1.290E-9 1.017E-8 2.461E-8 25 346
20 CAGTGTT,MIR-200A:MSigDB CAGTGTT,MIR-200A:MSigDB MSigDB 1.817E-11 1.290E-9 1.017E-8 2.709E-8 23 291
21 CAGTGTT,MIR-141:MSigDB CAGTGTT,MIR-141:MSigDB MSigDB 1.817E-11 1.290E-9 1.017E-8 2.709E-8 23 291
22 hsa-miR-500:PITA hsa-miR-500:PITA TOP PITA 2.715E-11 1.840E-9 1.451E-8 4.049E-8 24 325
23 hsa-miR-1264:PITA hsa-miR-1264:PITA TOP PITA 3.863E-11 2.504E-9 1.974E-8 5.760E-8 28 453
24 hsa-miR-499-5p:PITA hsa-miR-499-5p:PITA TOP PITA 4.442E-11 2.760E-9 2.176E-8 6.623E-8 20 224
25 miR-141:PicTar miR-141:PicTar PicTar 5.430E-11 3.239E-9 2.554E-8 8.096E-8 24 336
26 miR-144:PicTar miR-144:PicTar PicTar 7.225E-11 4.028E-9 3.176E-8 1.077E-7 27 433
27 miR-200b:PicTar miR-200b:PicTar PicTar 7.456E-11 4.028E-9 3.176E-8 1.112E-7 28 466
28 miR-181c:PicTar miR-181c:PicTar PicTar 7.767E-11 4.028E-9 3.176E-8 1.158E-7 29 500
29 miR-200c:PicTar miR-200c:PicTar PicTar 7.835E-11 4.028E-9 3.176E-8 1.168E-7 28 467
30 hsa-miR-34b:PITA hsa-miR-34b:PITA TOP PITA 1.162E-10 5.775E-9 4.554E-8 1.733E-7 25 379
31 miR-32:PicTar miR-32:PicTar PicTar 1.270E-10 6.106E-9 4.814E-8 1.893E-7 27 444
32 hsa-miR-942:PITA hsa-miR-942:PITA TOP PITA 1.479E-10 6.891E-9 5.433E-8 2.205E-7 23 323
33 hsa-miR-580:PITA hsa-miR-580:PITA TOP PITA 1.572E-10 7.105E-9 5.602E-8 2.345E-7 23 324
34 hsa-miR-922:PITA hsa-miR-922:PITA TOP PITA 1.710E-10 7.501E-9 5.914E-8 2.550E-7 25 386
35 hsa-miR-452:PITA hsa-miR-452:PITA TOP PITA 1.800E-10 7.670E-9 6.048E-8 2.685E-7 27 451
36 hsa-miR-802:PITA hsa-miR-802:PITA TOP PITA 1.892E-10 7.834E-9 6.177E-8 2.820E-7 27 452
37 hsa-miR-519e:PITA hsa-miR-519e:PITA TOP PITA 3.891E-10 1.427E-8 1.125E-7 5.801E-7 17 176
38 CAGTATT,MIR-200B:MSigDB CAGTATT,MIR-200B:MSigDB MSigDB 3.930E-10 1.427E-8 1.125E-7 5.860E-7 26 434
39 CAGTATT,MIR-200C:MSigDB CAGTATT,MIR-200C:MSigDB MSigDB 3.930E-10 1.427E-8 1.125E-7 5.860E-7 26 434
40 CAGTATT,MIR-429:MSigDB CAGTATT,MIR-429:MSigDB MSigDB 3.930E-10 1.427E-8 1.125E-7 5.860E-7 26 434
41 ATTCTTT,MIR-186:MSigDB ATTCTTT,MIR-186:MSigDB MSigDB 3.931E-10 1.427E-8 1.125E-7 5.862E-7 20 253
42 TTTGTAG,MIR-520D:MSigDB TTTGTAG,MIR-520D:MSigDB MSigDB 4.020E-10 1.427E-8 1.125E-7 5.993E-7 22 310
43 hsa-miR-579:PITA hsa-miR-579:PITA TOP PITA 4.129E-10 1.432E-8 1.129E-7 6.157E-7 26 435
44 hsa-miR-515-3p:PITA hsa-miR-515-3p:PITA TOP PITA 4.252E-10 1.441E-8 1.136E-7 6.339E-7 17 177
45 hsa-miR-498:PITA hsa-miR-498:PITA TOP PITA 4.841E-10 1.604E-8 1.265E-7 7.217E-7 20 256
46 hsa-miR-376c:TargetScan hsa-miR-376c:TargetScan TargetScan 5.309E-10 1.721E-8 1.357E-7 7.916E-7 16 156
47 hsa-miR-194:PITA hsa-miR-194:PITA TOP PITA 1.312E-9 4.163E-8 3.282E-7 1.956E-6 20 271
48 miR-367:PicTar miR-367:PicTar PicTar 1.823E-9 5.664E-8 4.466E-7 2.719E-6 22 336
49 hsa-miR-212:TargetScan hsa-miR-212:TargetScan TargetScan 2.777E-9 8.282E-8 6.530E-7 4.141E-6 20 283
50 hsa-miR-132:TargetScan hsa-miR-132:TargetScan TargetScan 2.777E-9 8.282E-8 6.530E-7 4.141E-6 20 283
Show 45 more annotations

17: Drug [Display Chart] 21473 annotations before applied cutoff / 22098 genes in category

ID Name Source pValue FDR B&H FDR B&Y Bonferroni Genes from Input Genes in Annotation
1 D010938 Plant Oils CTD 2.059E-13 4.420E-9 4.664E-8 4.420E-9 31 496
2 6142 DN Dorzolamide hydrochloride [130693-82-2]; Down 200; 11uM; HL60; HT HG-U133A Broad Institute CMAP 3.279E-10 3.520E-6 3.715E-5 7.041E-6 17 191
3 7504 DN 9-deoxy-9-methylene-16,16-dimethyl Prostaglandin E2; Down 200; 10uM; PC3; HT HG-U133A Broad Institute CMAP 5.308E-10 3.799E-6 4.009E-5 1.140E-5 17 197
4 630 UP colchicine; Up 200; 1uM; SKMEL5; HG-U133A Broad Institute CMAP 2.470E-9 1.326E-5 1.399E-4 5.303E-5 16 190
5 2784 DN Retrorsine [480-54-6]; Down 200; 11.4uM; MCF7; HT HG-U133A Broad Institute CMAP 3.341E-9 1.435E-5 1.514E-4 7.175E-5 16 194
6 3297 UP Bisacodyl [603-50-9]; Up 200; 11uM; MCF7; HT HG-U133A Broad Institute CMAP 4.495E-9 1.609E-5 1.698E-4 9.653E-5 15 171
7 4304 DN Mepenzolate bromide [76-90-4]; Down 200; 9.6uM; PC3; HT HG-U133A Broad Institute CMAP 1.755E-8 4.094E-5 4.319E-4 3.768E-4 15 189
8 970 DN 5230742; Down 200; 17uM; MCF7; HT HG-U133A EA Broad Institute CMAP 2.169E-8 4.094E-5 4.319E-4 4.658E-4 15 192
9 3035 DN Sulconazole nitrate [61318-91-0]; Down 200; 8.6uM; HL60; HT HG-U133A Broad Institute CMAP 2.493E-8 4.094E-5 4.319E-4 5.353E-4 15 194
10 2469 DN Norcyclobenzaprine [303-50-4]; Down 200; 15.4uM; HL60; HT HG-U133A Broad Institute CMAP 2.493E-8 4.094E-5 4.319E-4 5.353E-4 15 194
11 4312 DN Benfotiamine [22457-89-2]; Down 200; 8.6uM; PC3; HT HG-U133A Broad Institute CMAP 2.493E-8 4.094E-5 4.319E-4 5.353E-4 15 194
12 4309 DN Famprofazone [22881-35-2]; Down 200; 10.6uM; PC3; HT HG-U133A Broad Institute CMAP 2.670E-8 4.094E-5 4.319E-4 5.734E-4 15 195
13 843 DN 5279552; Down 200; 22uM; MCF7; HT HG-U133A EA Broad Institute CMAP 2.670E-8 4.094E-5 4.319E-4 5.734E-4 15 195
14 6129 DN Piperidolate hydrochloride [129-77-1]; Down 200; 11.2uM; HL60; HT HG-U133A Broad Institute CMAP 2.670E-8 4.094E-5 4.319E-4 5.734E-4 15 195
15 3032 DN Fluvastatin sodium salt [93957-55-2]; Down 200; 9.2uM; HL60; HT HG-U133A Broad Institute CMAP 2.860E-8 4.094E-5 4.319E-4 6.140E-4 15 196
16 6521 DN Ribavirin [36791-04-5]; Down 200; 16.4uM; MCF7; HT HG-U133A Broad Institute CMAP 3.745E-8 4.786E-5 5.050E-4 8.041E-4 15 200
17 C483909 torcetrapib CTD 3.789E-8 4.786E-5 5.050E-4 8.136E-4 19 328
18 4307 DN Pempidine tartrate [546-48-5]; Down 200; 13uM; PC3; HT HG-U133A Broad Institute CMAP 1.337E-7 1.491E-4 1.574E-3 2.871E-3 14 190
19 6054 DN Pramoxine hydrochloride [637-58-1]; Down 200; 12.2uM; MCF7; HT HG-U133A Broad Institute CMAP 1.522E-7 1.491E-4 1.574E-3 3.268E-3 14 192
20 4711 UP PNU-0251126 [267429-19-6]; Up 200; 10uM; MCF7; HT HG-U133A Broad Institute CMAP 1.522E-7 1.491E-4 1.574E-3 3.268E-3 14 192
21 5232 DN genistein; Down 200; 10uM; MCF7; HT HG-U133A Broad Institute CMAP 1.623E-7 1.491E-4 1.574E-3 3.484E-3 14 193
22 3562 DN D-cycloserine [68-41-7]; Down 200; 39.2uM; MCF7; HT HG-U133A Broad Institute CMAP 1.623E-7 1.491E-4 1.574E-3 3.484E-3 14 193
23 4305 DN Solasodine [126-17-0]; Down 200; 9.6uM; PC3; HT HG-U133A Broad Institute CMAP 1.729E-7 1.491E-4 1.574E-3 3.714E-3 14 194
24 7189 UP Iopamidol [60166-93-0]; Up 200; 5.2uM; MCF7; HT HG-U133A Broad Institute CMAP 1.729E-7 1.491E-4 1.574E-3 3.714E-3 14 194
25 3275 UP Digitoxigenin [143-62-4]; Up 200; 10.6uM; MCF7; HT HG-U133A Broad Institute CMAP 1.736E-7 1.491E-4 1.574E-3 3.728E-3 13 165
26 2470 DN Methionine sulfoximine (L) [15985-39-4]; Down 200; 22.2uM; HL60; HT HG-U133A Broad Institute CMAP 1.843E-7 1.522E-4 1.606E-3 3.957E-3 14 195
27 826 DN prazosin hydrochloride; Down 200; 10uM; MCF7; HT HG-U133A EA Broad Institute CMAP 2.089E-7 1.547E-4 1.632E-3 4.486E-3 14 197
28 2780 DN Isocorydine (+) [475-67-2]; Down 200; 11.8uM; MCF7; HT HG-U133A Broad Institute CMAP 2.089E-7 1.547E-4 1.632E-3 4.486E-3 14 197
29 2012 DN Zimelidine dihydrochloride monohydrate [61129-30-4]; Down 200; 9.8uM; HL60; HG-U133A Broad Institute CMAP 2.089E-7 1.547E-4 1.632E-3 4.486E-3 14 197
30 5105 DN Parthenolide [20554-84-1]; Down 200; 16.2uM; PC3; HT HG-U133A Broad Institute CMAP 4.453E-7 3.085E-4 3.255E-3 9.562E-3 13 179
31 3388 DN Crotamiton [483-63-6]; Down 200; 19.6uM; MCF7; HT HG-U133A Broad Institute CMAP 4.453E-7 3.085E-4 3.255E-3 9.562E-3 13 179
32 3887 DN Camptothecine (S,+) [7689-03-4]; Down 200; 11.4uM; MCF7; HT HG-U133A Broad Institute CMAP 5.386E-7 3.505E-4 3.698E-3 1.157E-2 13 182
33 1280 UP Ritodrine hydrochloride [23239-51-2]; Up 200; 12.4uM; HL60; HT HG-U133A Broad Institute CMAP 5.386E-7 3.505E-4 3.698E-3 1.157E-2 13 182
34 7498 DN irinotecan HCl; Down 200; 100uM; MCF7; HT HG-U133A Broad Institute CMAP 5.734E-7 3.621E-4 3.821E-3 1.231E-2 13 183
35 3803 DN Flutamide [13311-84-7]; Down 200; 14.4uM; PC3; HT HG-U133A Broad Institute CMAP 9.322E-7 5.266E-4 5.557E-3 2.002E-2 13 191
36 7435 DN Bupivacaine hydrochloride [18010-40-7]; Down 200; 12.4uM; MCF7; HT HG-U133A Broad Institute CMAP 9.322E-7 5.266E-4 5.557E-3 2.002E-2 13 191
37 4303 DN Flunisolide [3385-03-3]; Down 200; 9.2uM; PC3; HT HG-U133A Broad Institute CMAP 9.322E-7 5.266E-4 5.557E-3 2.002E-2 13 191
38 6808 DN Estropipate [7280-37-7]; Down 200; 9.2uM; MCF7; HT HG-U133A Broad Institute CMAP 9.889E-7 5.266E-4 5.557E-3 2.123E-2 13 192
39 2471 DN Phenacetin [62-44-2]; Down 200; 22.4uM; HL60; HT HG-U133A Broad Institute CMAP 9.889E-7 5.266E-4 5.557E-3 2.123E-2 13 192
40 4274 DN Fenoprofen calcium salt dihydrate [53746-45-5]; Down 200; 7.2uM; PC3; HT HG-U133A Broad Institute CMAP 9.889E-7 5.266E-4 5.557E-3 2.123E-2 13 192
41 2735 DN Cefoxitin sodium salt [33564-30-6]; Down 200; 8.8uM; HL60; HT HG-U133A Broad Institute CMAP 1.111E-6 5.266E-4 5.557E-3 2.387E-2 13 194
42 2875 DN Thiocolchicoside [602-41-5]; Down 200; 7uM; MCF7; HT HG-U133A Broad Institute CMAP 1.178E-6 5.266E-4 5.557E-3 2.529E-2 13 195
43 3034 DN Capsaicin [404-86-4]; Down 200; 13uM; HL60; HT HG-U133A Broad Institute CMAP 1.178E-6 5.266E-4 5.557E-3 2.529E-2 13 195
44 2708 DN Hexylcaine hydrochloride [532-76-3]; Down 200; 13.4uM; HL60; HT HG-U133A Broad Institute CMAP 1.178E-6 5.266E-4 5.557E-3 2.529E-2 13 195
45 4393 DN Pancuronium bromide [15500-66-0]; Down 200; 5.4uM; MCF7; HT HG-U133A Broad Institute CMAP 1.178E-6 5.266E-4 5.557E-3 2.529E-2 13 195
46 3237 DN Adenosine 5'-monophosphate monohydrate [18422-05-4]; Down 200; 11uM; MCF7; HT HG-U133A Broad Institute CMAP 1.178E-6 5.266E-4 5.557E-3 2.529E-2 13 195
47 3971 DN Phentolamine hydrochloride [73-05-2]; Down 200; 12.6uM; MCF7; HT HG-U133A Broad Institute CMAP 1.247E-6 5.266E-4 5.557E-3 2.679E-2 13 196
48 7552 UP 9-deoxy-9-methylene-16,16-dimethyl Prostaglandin E2; Up 200; 10uM; MCF7; HT HG-U133A Broad Institute CMAP 1.321E-6 5.266E-4 5.557E-3 2.836E-2 13 197
49 5302 UP Mimosine [500-44-7]; Up 200; 20.2uM; MCF7; HT HG-U133A Broad Institute CMAP 1.321E-6 5.266E-4 5.557E-3 2.836E-2 13 197
50 1903 DN Oxethazaine [126-27-2]; Down 200; 8.6uM; PC3; HG-U133A Broad Institute CMAP 1.321E-6 5.266E-4 5.557E-3 2.836E-2 13 197
Show 45 more annotations

18: Disease [Display Chart] 2632 annotations before applied cutoff / 16150 genes in category

ID Name Source pValue FDR B&H FDR B&Y Bonferroni Genes from Input Genes in Annotation
1 umls:C0346429 Multiple malignancy DisGeNET BeFree 2.296E-6 3.373E-3 2.851E-2 6.042E-3 13 190
2 umls:C1333394 Endometrial intraepithelial neoplasia DisGeNET BeFree 2.563E-6 3.373E-3 2.851E-2 6.746E-3 3 3
3 umls:C0281784 Benign Meningioma DisGeNET BeFree 6.147E-6 5.393E-3 4.559E-2 1.618E-2 5 20
4 umls:C0553580 Ewings sarcoma DisGeNET Curated 4.354E-5 2.181E-2
1.843E-1
1.146E-1
 12 215
5 umls:C1332167 Adenoid cystic breast carcinoma DisGeNET BeFree 4.971E-5 2.181E-2
1.843E-1
1.308E-1
 3 6
6 umls:C1512260 grade I meningioma DisGeNET BeFree 4.971E-5 2.181E-2
1.843E-1
1.308E-1
 3 6
7 umls:C0021841 Intestinal Neoplasms DisGeNET Curated 1.102E-4 4.143E-2
3.502E-1
2.900E-1
 9 136
8 umls:C1535939 Pneumocystis jiroveci pneumonia DisGeNET BeFree 1.864E-4 4.590E-2
3.880E-1
4.905E-1
 6 61
9 umls:C1275859 Transitional cell dysplasia DisGeNET BeFree 1.881E-4 4.590E-2
3.880E-1
4.951E-1
 2 2
10 umls:C1334655 Mediastinal Germ Cell Tumor DisGeNET Curated 1.881E-4 4.590E-2
3.880E-1
4.951E-1
 2 2
11 umls:C0346627 Intestinal Cancer DisGeNET BeFree 2.086E-4 4.590E-2
3.880E-1
5.490E-1
 5 40
12 umls:C0206684 Sebaceous Adenocarcinoma DisGeNET BeFree 2.093E-4 4.590E-2
3.880E-1
5.508E-1
 4 22
13 umls:C0010606 Adenoid Cystic Carcinoma DisGeNET Curated 2.453E-4 4.966E-2
4.198E-1
6.456E-1
 10 185
Show 8 more annotations